Cargando…

Look Action for Health in Diabetes trial: What we have learned in terms of real world practice and clinical trials

Detalles Bibliográficos
Autores principales:	Kwok, Ching-Fai, Ho, Low-Tone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234225/ https://www.ncbi.nlm.nih.gov/pubmed/25422762 http://dx.doi.org/10.1111/jdi.12231

Ejemplares similares

Severe hypoglycemia predicts major adverse outcomes in diabetic patients undergoing glycemic control regimes
por: Kwok, Ching‐Fai, et al.
Publicado: (2011)

Surrogate end points of quality of life assessment: have we really found what we are looking for?
por: Tassinari, Davide
Publicado: (2003)

Endometriosis and the effects of dietary interventions: what are we looking for?
por: Nap, Annemiek, et al.
Publicado: (2022)

Qualitative research on community experiences in large HIV research trials: what have we learned?
por: Camlin, Carol S, et al.
Publicado: (2018)

Clinical trial registration during COVID-19 and beyond in the African context: what have we learned?
por: Mathebula, Lindi, et al.
Publicado: (2022)

What can we learn from real world studies on direct oral anticoagulants?
por: Coppens, M.
Publicado: (2017)

Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials
por: Mookerjee, Rajeshwar P, et al.
Publicado: (2008)

Commentary: Thoracoscopic-Assisted Rib Plating: Where We Are and What We Have Learned
por: Kim, Seon Hee, et al.
Publicado: (2023)

Understanding environmental influences on nutrition and physical activity behaviors: where should we look and what should we count?
por: Ball, Kylie, et al.
Publicado: (2006)

Gene expression in human sepsis: what have we learned?
por: Russell, James A
Publicado: (2011)

Metasynthetic Madness: What Kind of Monster Have We Created?
por: Thorne, Sally
Publicado: (2016)

Time-restricted feeding: what we have done and what more we can do?
por: Sun, Yuning, et al.
Publicado: (2023)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Could an Open-Source Clinical Trial Data-Management System Be What We Have All Been Looking For?
por: Fegan, Greg W, et al.
Publicado: (2008)

IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future
por: Incorvaia, Cristoforo, et al.
Publicado: (2017)

What have we learned from cancer immunotherapy in the last 3 years?
por: Ascierto, Paolo A, et al.
Publicado: (2014)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Coronavirus Disease 2019 and Acute Kidney Injury: What Have We Learned?
por: Husain-Syed, Faeq, et al.
Publicado: (2021)

COVID-19 and patient engagement in health research: What have we learned?
por: Denegri, Simon, et al.
Publicado: (2021)

What Can We Learn From Clinical Trials of Exon Skipping for DMD?
por: Lu, Qi-long, et al.
Publicado: (2014)

UKLS trial: looking beyond negative results
por: Darrason, Marie, et al.
Publicado: (2021)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

What we have learned from the past and how we should look forward
por: Wellmer, Friedrich-W.
Publicado: (2022)

Can real-world data really replace randomised clinical trials?
por: Ramagopalan, Sreeram V., et al.
Publicado: (2020)

Immunocompromised patients have been neglected in COVID-19 trials: a call for action
por: Trøseid, Marius, et al.
Publicado: (2022)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt
por: Ahmed, Ahmed Ashour, et al.
Publicado: (2005)

Parliaments lead the change for women’s, children’s and adolescents’ health: what have we learnt?
por: Toure, Kadidiatou, et al.
Publicado: (2021)

Advancing ‘real-world’ trials that take account of social context and human volition
por: Hansen, Anders Blædel Gottlieb, et al.
Publicado: (2017)

What we see depends on what we look for
por: Tomšič, Anton, et al.
Publicado: (2020)

Reducing Racial Inequities in Health: Using What We Already Know to Take Action
por: Williams, David R., et al.
Publicado: (2019)

Breakthrough COVID-19 Infections: What Are They and What Do They Look Like?
por: Elicker, Brett M.
Publicado: (2022)

Treating transgenic Alzheimer mice with a β-secretase inhibitor, what have we learned?
por: Tang, Jordan, et al.
Publicado: (2011)

Proximal tubular dysfunction in patients with COVID-19: what have we learnt so far?
por: Braun, Fabian, et al.
Publicado: (2020)

Estimating maternal mortality: what have we learned from 16 years of surveys in Afghanistan?
por: Alba, Sandra, et al.
Publicado: (2020)

Cannabis use in first episode psychosis: what we have tried and why it hasn’t worked
por: McDonell, Michael G., et al.
Publicado: (2019)

Violence against children in the time of COVID-19: What we have learned, what remains unknown and the opportunities that lie ahead
por: Fore, Henrietta H.
Publicado: (2021)

What have we learnt from Covid-19 Pandemia? Looking to the future
por: de Granda-Orive, J.I., et al.
Publicado: (2023)

Targeting cytokine storm in COVID-19: what have we learned?
por: Ridker, Paul M
Publicado: (2021)

Romosozumab, clinical trials, and real-world care of patients with osteoporosis
por: Lewiecki, E. Michael
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5t7d3t796sqeplnjmlmtndaj6f